TriangleNCT02113982 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- pi Sponsor Employee
- false
- restrictive Agreement
- false
- limitations And Caveats
- description
- This study was limited by lack of randomization due to the ultra-rare nature of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Patients lacked established response criteria for BPDCN prior to STML-401-0114.
- point Of Contact
- clinicaltrials@menarinistemline.com
- organization
- Stemline Therapeutics, Inc.
- phone
- 877-332-7967
- title
- Ira Gupta, MD
Complete source fields
- certain Agreement
- pi Sponsor Employee
- false
- restrictive Agreement
- false
- limitations And Caveats
- description
- This study was limited by lack of randomization due to the ultra-rare nature of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Patients lacked established response criteria for BPDCN prior to STML-401-0114.
- point Of Contact
- clinicaltrials@menarinistemline.com
- organization
- Stemline Therapeutics, Inc.
- phone
- 877-332-7967
- title
- Ira Gupta, MD
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice